Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rossi-Ferrini

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Thrombosis Research|October 15, 1989
Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentratesM Morfini, D Rafanelli, E Filimberti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1988
In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemiaR Saccardi, P A Bernabei, R Bezzini, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacsA Messori, G Longo, M Morfini, et al.
Chemotherapy|January 1, 1991
Daunorubicin impairs 1-beta-D-arabinofuranosylcytosine uptakeO Dal Pozzo, P A Bernabei, L Lombardini, et al.
Leukemia|March 1, 1992
Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patientsA M Vannucchi, A Bosi, A Grossi, et al.
Acta Haematologica|January 1, 1982
Primary conjunctival lymphoma: response to chemotherapy in 4 casesG Bellesi, S di Lollo, A Bosi, et al.
Haematologica|January 1, 1995
In vivo administration of stem cell factor enhances both proliferation and maturation of murine megakaryocytesA Grossi, A M Vannucchi, P Bacci, et al.
Haematologica|September 1, 1985
Comparison of two pharmacokinetic techniques for individualizing factor VIII dosage in haemophilia patientsM Morfini, T H Grasela, G Longo, et al.
Hematological Oncology|January 1, 1993
The role of haematopoietic growth factors in the treatment of myelodysplastic syndromesP Rossi Ferrini, V Santini, S Ciolli, et al.
Leukemia & Lymphoma|August 1, 1995
Low-dose cytosine arabinoside in patients with acute myeloid leukemia not eligible for standard chemotherapyA Pascarella, C Marrani, F Leoni, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Thrombosis Research|October 15, 1989
Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentratesM Morfini, D Rafanelli, E Filimberti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1988
In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemiaR Saccardi, P A Bernabei, R Bezzini, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacsA Messori, G Longo, M Morfini, et al.
Chemotherapy|January 1, 1991
Daunorubicin impairs 1-beta-D-arabinofuranosylcytosine uptakeO Dal Pozzo, P A Bernabei, L Lombardini, et al.
Leukemia|March 1, 1992
Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patientsA M Vannucchi, A Bosi, A Grossi, et al.
Acta Haematologica|January 1, 1982
Primary conjunctival lymphoma: response to chemotherapy in 4 casesG Bellesi, S di Lollo, A Bosi, et al.
Haematologica|January 1, 1995
In vivo administration of stem cell factor enhances both proliferation and maturation of murine megakaryocytesA Grossi, A M Vannucchi, P Bacci, et al.
Haematologica|September 1, 1985
Comparison of two pharmacokinetic techniques for individualizing factor VIII dosage in haemophilia patientsM Morfini, T H Grasela, G Longo, et al.
Hematological Oncology|January 1, 1993
The role of haematopoietic growth factors in the treatment of myelodysplastic syndromesP Rossi Ferrini, V Santini, S Ciolli, et al.
Leukemia & Lymphoma|August 1, 1995
Low-dose cytosine arabinoside in patients with acute myeloid leukemia not eligible for standard chemotherapyA Pascarella, C Marrani, F Leoni, et al.
Pageof 8